Case Study: SanoPass enables investor exit with SeedBlink

SanoPass enables investor exit in 2.5 years with SeedBlink

SeedBlink provided an exit solution for investors in the MedTech startup SanoPass. The challenge was to ensure a seamless and profitable exit process that required meticulous coordination between stakeholders to meet all legal and financial obligations, while also providing a fair valuation to maintain investor trust.

Through its Ventures product, SeedBlink implemented a comprehensive exit strategy that facilitated smooth transactions and handled all financial and legal documentation. This resulted in a successful acquisition by MedLife just two and a half years after the initial investment, providing early financial rewards and a significant return for investors, marking SeedBlink's first portfolio exit.

SanoPass